PMID- 27062197 OWN - NLM STAT- MEDLINE DCOM- 20170331 LR - 20170331 IS - 1747-0285 (Electronic) IS - 1747-0277 (Linking) VI - 88 IP - 3 DP - 2016 Sep TI - Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitors. PG - 380-5 LID - 10.1111/cbdd.12765 [doi] AB - A series of novel 5-alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones bearing various substituents at the C-2 position of the pyrimidinone ring were synthesized using a facile route and evaluated for their anti-HIV activity in MT-4 cells. The biological results demonstrated that the majority of the newly designed compounds possessed moderate efficiency in inhibiting the replication of the wild-type (WT) HIV-1 strain (IIIB ) with EC50 values in the range from 0.10 to 5.39 mum. Among them, 5b1 and 5b3 proved to be the two most active inhibitors against WT HIV-1 with EC50 values of 0.10 and 0.12 mum, respectively, which were more active than nevirapine (NVP) in the same assay. In addition, HIV-1 reverse-transcriptase (RT) inhibition assay indicated that the representative compound 5b1 showed affinity to WT HIV-1 RT, and inhibited the activity of RT with an IC50 value superior to the reference drug NVP. Moreover, the preliminary structure-activity relationship (SAR) and the molecular modeling analysis of these new derivatives are also discussed. CI - (c) 2016 John Wiley & Sons A/S. FAU - Li, Wenxin AU - Li W AD - Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji'nan, Shandong, China. FAU - Huang, Boshi AU - Huang B AD - Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji'nan, Shandong, China. FAU - Kang, Dongwei AU - Kang D AD - Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji'nan, Shandong, China. FAU - De Clercq, Erik AU - De Clercq E AD - Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. FAU - Daelemans, Dirk AU - Daelemans D AD - Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. FAU - Pannecouque, Christophe AU - Pannecouque C AD - Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. FAU - Zhan, Peng AU - Zhan P AD - Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji'nan, Shandong, China. FAU - Liu, Xinyong AU - Liu X AD - Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji'nan, Shandong, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160621 PL - England TA - Chem Biol Drug Des JT - Chemical biology & drug design JID - 101262549 RN - 0 (Anti-HIV Agents) RN - 0 (Pyrimidines) RN - 0 (Reverse Transcriptase Inhibitors) SB - IM MH - Anti-HIV Agents/chemical synthesis/*chemistry/*pharmacology MH - Cell Line MH - *Drug Design MH - Drug Evaluation, Preclinical MH - HIV-1/*drug effects MH - Humans MH - Pyrimidines/chemistry/*pharmacology MH - Reverse Transcriptase Inhibitors/chemical synthesis/*chemistry/*pharmacology OTO - NOTNLM OT - HIV-1 OT - NNRTIs OT - S-DABOs OT - anti-HIV-1 activity OT - drug design EDAT- 2016/04/12 06:00 MHDA- 2017/04/01 06:00 CRDT- 2016/04/11 06:00 PHST- 2015/11/18 00:00 [received] PHST- 2016/03/09 00:00 [revised] PHST- 2016/03/10 00:00 [accepted] PHST- 2016/04/11 06:00 [entrez] PHST- 2016/04/12 06:00 [pubmed] PHST- 2017/04/01 06:00 [medline] AID - 10.1111/cbdd.12765 [doi] PST - ppublish SO - Chem Biol Drug Des. 2016 Sep;88(3):380-5. doi: 10.1111/cbdd.12765. Epub 2016 Jun 21.